Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB

Infection and Immunity

Volumn 79, Issue 9, 2011, Pages 3541-3551

  Mitchell, Gabriel ^a   Grondin, Gilles ^a   Bilodeau, Ginette ^b   Cantin, André M ^b   Malouin, François ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SHORT HAIRPIN RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; CELL POLARITY; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CELL LINE; CELL POLARITY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; HUMANS; LUNG; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; RESPIRATORY MUCOSA; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80052318160     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00078-11     Document Type: Article

References (67)

1. Alexander, E. H., and M. C. Hudson. 2001. Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl. Microbiol. Biotechnol. 56:361-366.
2. Archer, G. L. 1998. Staphylococcus aureus: a well-armed pathogen. Clin. Infect. Dis. 26:1179-1181.
3. Atalla, H., et al. 2008. Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis. Foodborne Pathog. Dis. 5:785-799.
4. Atalla, H., C. Gyles, and B. Mallard. 2009. Persistence of a Staphylococcus aureus small colony variants (S. aureus SCV) within bovine mammary epithelial cells. Vet. Microbiol. 143:319-328.
5. Balwit, J. M., P. van Langevelde, J. M. Vann, and R. A. Proctor. 1994. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170:1033-1037.
6. Brouillette, E., A. Martinez, B. J. Boyll, N. E. Allen, and F. Malouin. 2004. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol. Med. Microbiol. 41:35-41.
7. Canadian Cystic Fibrosis Foundation. 2007. Patient data registry report. Canadian Cystic Fibrosis Foundation, Toronto, ON, Canada.
8. Cannon, C. L., M. P. Kowalski, K. S. Stopak, and G. B. Pier. 2003. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell Mol. Biol. 29:188-197.
9. Cantin, A. M., G. Bilodeau, C. Ouellet, J. Liao, and J. W. Hanrahan. 2006. Oxidant stress suppresses CFTR expression. Am. J. Physiol. Cell Physiol. 290:C262-C270.
10. Cantin, A. M., et al. 2006. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am. J. Respir. Crit. Care Med. 173:1139-1144.
11. Carterson, A. J., et al. 2005. A549 lung epithelial cells grown as threedimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect. Immun. 73:1129-1140.
12. Cuny, C., et al. 2010. Emergence of methicillin-resistant Staphylococcus aureus (MRSA) in different animal species. Int. J. Med. Microbiol. 300:109-117.
13. Cystic Fibrosis Foundation. 2008. Patient registry annual report. Cystic Fibrosis Foundation, Washington, DC.
14. Di, A., et al. 2006. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell Biol. 8:933-944.
15. Döring, G., and E. Gulbins. 2009. Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell. Microbiol. 11:208-216.
16. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
17. Fang, X., et al. 2006. Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L242-L249.
18. Fleiszig, S. M., et al. 1997. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect. Immun. 65:2861-2867.
19. Goering, R. V., A. Bauernfeind, W. Lenz, and B. Przyklenk. 1990. Staphylococcus aureus in patients with cystic fibrosis: an epidemiological analysis using a combination of traditional and molecular methods. Infection 18:57-60.
20. Goerke, C., and C. Wolz. 2004. Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection. Int. J. Med. Microbiol. 294:195-202.
21. Grainger, C. I., L. L. Greenwell, D. J. Lockley, G. P. Martin, and B. Forbes. 2006. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm. Res. 23:1482-1490.
22. Hunter, M. J., et al. 2010. Expression of wild-type CFTR suppresses NF-κB-driven inflammatory signalling. PLoS One 5:e11598.
23. Jarry, T. M., and A. L. Cheung. 2006. Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial epithelial cell line than from its normal counterpart. Infect. Immun. 74:2568-2577.
24. Joo, N. S., D. J. Lee, K. M. Winges, A. Rustagi, and J. J. Wine. 2004. Regulation of antiprotease and antimicrobial protein secretion by airway submucosal gland serous cells. J. Biol. Chem. 279:38854-38860.
25. Joseph, T., D. Look, and T. Ferkol. 2005. NF-κB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L471-L479.
26. Kahl, B., et al. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177:1023-1029.
27. Kahl, B. C., et al. 2005. Thymidine-dependent Staphylococcus aureus smallcolony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect. Immun. 73:4119-4126.
28. Krivan, H. C., D. D. Roberts, and V. Ginsburg. 1988. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAcβ1-4Gal found in some glycolipids. Proc. Natl. Acad. Sci. U. S. A. 85:6157-6161.
29. 2 receptor. Eur. J. Immunol. 39:2895-2905.
30. Lowy, F. D. 2000. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol. 8:341-343.
31. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
32. Ma, T., et al. 2002. Thiazolidinone CFTR inhibitor identified by highthroughput screening blocks cholera toxin-induced intestinal fluid secretion. J. Clin. Invest. 110:1651-1658.
33. Malachowa, N., et al. 2005. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J. Clin. Microbiol. 43:3095-3100.
34. Mitchell, G., et al. 2010. A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb. Pathog. 48:18-27.
35. Mitchell, G., et al. 2011. Tomatidine inhibits the replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells. Antimicrob. Agents Chemother. 55:1937-1945.
36. Mitchell, G., et al. 2008. Staphylococcus aureus SigB activity promotes a strong fibronectin-bacterium interaction which may sustain host tissue colonization by small-colony variants isolated from cystic fibrosis patients. Mol. Microbiol. 70:1540-1555.
37. Mitchell, G., et al. 2010. Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiol. 10:33.
38. Moisan, H., et al. 2006. Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J. Bacteriol. 188:64-76.
39. Nickerson, C. A., et al. 2001. Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis. Infect. Immun. 69:7106-7120.
40. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
41. Oviedo-Boyso, J., et al. 2008. Internalization of Staphylococcus aureus by bovine endothelial cells is associated with the activity state of NF-κB and modulated by the pro-inflammatory cytokines TNF-α and IL-1β. Scand. J. Immunol. 67:169-176.
42. -secretion in Calu-3 cells requires prostaglandin release and CFTR activation. Am. J. Physiol. Cell Physiol. 290:C1189-C1198.
43. Perkins, N. D. 2007. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8:49-62.
44. Plotkowski, M. C., et al. 1999. Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am. J. Respir. Cell Mol. Biol. 20:880-890.
45. Proctor, R. A., et al. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4:295-305.
46. Ramesh Babu, P. B., A. Chidekel, L. Utidjian, and T. H. Shaffer. 2004. Regulation of apical surface fluid and protein secretion in human airway epithelial cell line Calu-3. Biochem. Biophys. Res. Commun. 319:1132-1137.
47. 2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J. Biol. Chem. 276:19267-19275.
48. Riordan, J. R. 2008. CFTR function and prospects for therapy. Annu. Rev. Biochem. 77:701-726.
49. Rubin, B. K. 2007. CFTR is a modulator of airway inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L381-L382.
50. Sabat, A., et al. 2003. New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J. Clin. Microbiol. 41:1801-1804.
51. Saiman, L., and A. Prince. 1993. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92:1875-1880.
52. Schröder, A., R. Kland, A. Peschel, C. von Eiff, and M. Aepfelbacher. 2006. Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes. Med. Microbiol. Immunol. 195:185-194.
53. Sendi, P., and R. A. Proctor. 2009. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 17:54-58.
54. B activity in a Staphylococcus aureus hemB mutant. J. Bacteriol. 187:7397-7406.
55. 1. Cell. Microbiol. 1:101-117.
56. Teichgräber, V., et al. 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 14:382-391.
57. Tenover, F. C., R. R. Vaughn, L. K. McDougal, G. E. Fosheim, and J. E. McGowan, Jr. 2007. Multiple-locus variable-number tandem-repeat assay analysis of methicillin-resistant Staphylococcus aureus strains. J. Clin. Microbiol. 45:2215-2219.
58. Tirouvanziam, R., et al. 2000. Inflammation and infection in naive human cystic fibrosis airway grafts. Am. J. Respir. Cell Mol. Biol. 23:121-127.
59. Tobe, M., et al. 2003. Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation. Bioorg. Med. Chem. 11:383-391.
60. Tuchscherr, L., et al. 2010. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J. Infect. Dis. 202:1031-1040.
61. Tuchscherr, L., et al. 2011. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol. Med. 3:129-141.
62. Vaudaux, P., et al. 2002. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70:5428-5437.
63. Vesga, O., et al. 1996. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 173:739-742.
64. Vij, N., S. Mazur, and P. L. Zeitlin. 2009. CFTR is a negative regulator of NFκB mediated innate immune response. PLoS One 4:e4664.
65. von Eiff, C., et al. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4706-4712.
66. Wang, J. H., Y. J. Zhou, and P. He. 2010. Staphylococcus aureus induces apoptosis of human monocytic U937 cells via NF-κB signaling pathways. Microb. Pathog. 49:252-259.
67. Zander, J., et al. 2008. Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect. Immun. 76:1333-1339.